FR2070102A1 - 1 subst phenyl 2 amino ethanols useful as beta - adrenergic agents peripheral vasodilators and hypo- - Google Patents

1 subst phenyl 2 amino ethanols useful as beta - adrenergic agents peripheral vasodilators and hypo-

Info

Publication number
FR2070102A1
FR2070102A1 FR7035552A FR7035552A FR2070102A1 FR 2070102 A1 FR2070102 A1 FR 2070102A1 FR 7035552 A FR7035552 A FR 7035552A FR 7035552 A FR7035552 A FR 7035552A FR 2070102 A1 FR2070102 A1 FR 2070102A1
Authority
FR
France
Prior art keywords
alkyl
subst
phenyl
useful
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7035552A
Other languages
English (en)
French (fr)
Other versions
FR2070102B1 (nl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Continental Pharma Inc
Original Assignee
Continental Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma Inc filed Critical Continental Pharma Inc
Publication of FR2070102A1 publication Critical patent/FR2070102A1/fr
Application granted granted Critical
Publication of FR2070102B1 publication Critical patent/FR2070102B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
FR7035552A 1969-10-01 1970-10-01 1 subst phenyl 2 amino ethanols useful as beta - adrenergic agents peripheral vasodilators and hypo- Granted FR2070102A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE79767 1969-10-01
BE93537 1970-09-03

Publications (2)

Publication Number Publication Date
FR2070102A1 true FR2070102A1 (en) 1971-09-10
FR2070102B1 FR2070102B1 (nl) 1974-08-23

Family

ID=25647478

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7035552A Granted FR2070102A1 (en) 1969-10-01 1970-10-01 1 subst phenyl 2 amino ethanols useful as beta - adrenergic agents peripheral vasodilators and hypo-

Country Status (17)

Country Link
JP (1) JPS541693B1 (nl)
AR (1) AR194457A1 (nl)
AT (1) AT323135B (nl)
CA (1) CA953723A (nl)
CH (1) CH542177A (nl)
CS (1) CS191158B2 (nl)
DK (1) DK147853C (nl)
FI (1) FI52714C (nl)
FR (1) FR2070102A1 (nl)
HU (1) HU167354B (nl)
IE (1) IE34545B1 (nl)
NL (1) NL156688B (nl)
NO (1) NO132865C (nl)
OA (1) OA03659A (nl)
SE (1) SE384855B (nl)
SU (1) SU578860A3 (nl)
YU (1) YU35580B (nl)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2183681A1 (nl) * 1972-03-20 1973-12-21 Smith Kline French Lab
FR2416012A1 (fr) * 1978-02-01 1979-08-31 Wellcome Found Derives de l'imidazole et medicament contenant ces substances
FR2471374A1 (fr) * 1979-12-07 1981-06-19 Cosmos Enterprise Nouveau procede pour la preparation du 1-(4-hydroxyphenyl)-2-(4-benzylpiperidino)-propanol et de ses sels d'addition d'acides
FR2503705A1 (fr) * 1981-04-14 1982-10-15 Synthelabo Derives de phenethanolamine, leur preparation et leur application en therapeutique
EP0069012A1 (fr) * 1981-06-29 1983-01-05 Societe De Recherches Industrielles S.O.R.I. Dérivés de benzoyl-phényl-pipéridine, procédé de préparation et application en thérapeutique
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2537132A1 (fr) * 1982-12-06 1984-06-08 Lafon Labor Nouveaux derives soufres de 2-amino-1-phenyl-1-ethanol, utilisation en therapeutique et procede de preparation
WO1992013834A1 (en) * 1991-02-04 1992-08-20 Zeneca Limited Preparation of trisubstituted benzoic acids and intermediates
WO1997017324A1 (fr) * 1995-11-10 1997-05-15 Rhodia Chimie Procede d'acylation d'un thioether aromatique
WO1998025903A1 (fr) * 1996-12-13 1998-06-18 Sanofi 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201714736D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1503517A (fr) * 1965-04-22 1967-12-01 Bayer Ag Procédé de fabrication de d-(-)-n-alcoyl-1-phényl-2-aminoéthanols

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1503517A (fr) * 1965-04-22 1967-12-01 Bayer Ag Procédé de fabrication de d-(-)-n-alcoyl-1-phényl-2-aminoéthanols

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2183681A1 (nl) * 1972-03-20 1973-12-21 Smith Kline French Lab
FR2416012A1 (fr) * 1978-02-01 1979-08-31 Wellcome Found Derives de l'imidazole et medicament contenant ces substances
FR2471374A1 (fr) * 1979-12-07 1981-06-19 Cosmos Enterprise Nouveau procede pour la preparation du 1-(4-hydroxyphenyl)-2-(4-benzylpiperidino)-propanol et de ses sels d'addition d'acides
FR2503705A1 (fr) * 1981-04-14 1982-10-15 Synthelabo Derives de phenethanolamine, leur preparation et leur application en therapeutique
EP0063084A1 (fr) * 1981-04-14 1982-10-20 Synthelabo Dérivés de phénéthanolamine, leur préparation et leur application en thérapeutique
US4528294A (en) * 1981-06-29 1985-07-09 Societe De Recherches Industrielle S.O.R.I. Benzoyl-phenyl-piperidine derivatives
EP0069012A1 (fr) * 1981-06-29 1983-01-05 Societe De Recherches Industrielles S.O.R.I. Dérivés de benzoyl-phényl-pipéridine, procédé de préparation et application en thérapeutique
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
EP0109317A2 (fr) * 1982-10-13 1984-05-23 Synthelabo Dérivés de phényl-1 pipéridino-2 propanol, leur préparation, et médicaments qui les contiennent
EP0109317A3 (en) * 1982-10-13 1984-08-08 Synthelabo Phenyl-1-piperidino-2-propanol derivatives, their preparation and medicaments containing them
FR2537132A1 (fr) * 1982-12-06 1984-06-08 Lafon Labor Nouveaux derives soufres de 2-amino-1-phenyl-1-ethanol, utilisation en therapeutique et procede de preparation
WO1992013834A1 (en) * 1991-02-04 1992-08-20 Zeneca Limited Preparation of trisubstituted benzoic acids and intermediates
WO1997017324A1 (fr) * 1995-11-10 1997-05-15 Rhodia Chimie Procede d'acylation d'un thioether aromatique
FR2741067A1 (fr) * 1995-11-10 1997-05-16 Rhone Poulenc Chimie Procede d'acylation d'un thioether aromatique
WO1998025903A1 (fr) * 1996-12-13 1998-06-18 Sanofi 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer
FR2757160A1 (fr) * 1996-12-13 1998-06-19 Sanofi Sa 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
JPS541693B1 (nl) 1979-01-27
IE34545L (en) 1971-04-01
FI52714B (nl) 1977-08-01
FI52714C (fi) 1977-11-10
DK147853B (da) 1984-12-24
CH542177A (fr) 1973-09-30
IE34545B1 (en) 1975-06-11
FR2070102B1 (nl) 1974-08-23
NO132865B (nl) 1975-10-13
OA03659A (fr) 1971-12-24
YU238570A (en) 1980-09-25
NO132865C (nl) 1976-01-21
HU167354B (nl) 1975-09-27
SU578860A3 (ru) 1977-10-30
AR194457A1 (es) 1973-07-23
SE384855B (sv) 1976-05-24
NL156688B (nl) 1978-05-16
CS191158B2 (en) 1979-06-29
CA953723A (en) 1974-08-27
DK147853C (da) 1986-05-20
YU35580B (en) 1981-04-30
NL7014444A (nl) 1971-04-05
AT323135B (de) 1975-06-25

Similar Documents

Publication Publication Date Title
FR2070102A1 (en) 1 subst phenyl 2 amino ethanols useful as beta - adrenergic agents peripheral vasodilators and hypo-
SE7713134L (sv) Heterocykliska foreningar och forfarande for framstellning derav
ES441673A1 (es) Un procedimiento para la preparacion de sales de biguanida.
DE69219089D1 (de) 5,6-Disubstituierte-3-Pyridylmethylammoniumhalogenid-Verbindungen, verwendbar für die Herstellung von 5-(substituierte Methyl)-2,3-Pyridindicarbonsäuren
NO933425L (no) Nye aktive forbindelser
FI923050A0 (fi) Nya benzomorfaner och deras anvaendning som laekemedel.
ATE232386T1 (de) Neue endiyn-chinonimine und verfahren zu deren herstellung und verwendung
ES531062A0 (es) Procedimiento para la preparacion de un nuevo compuesto heterociclico
ES417638A1 (es) Procedimiento para preparar oxazoles 2,4,5-trisustituidos.
ATE27452T1 (de) Substituierte o-phenylendiaminderivate.
AU534746B2 (en) Oxime derivatives
NO151892C (no) Fremgangsmaate for fremstilling av basisk substituerte fenylacetonitriler.
BE811324A (en) Amino alkyl 2,6-dialkyl-4-aryl-1,4 dihydropyridine-3, carboxylates - useful as cerebral vasodilators and musculotropic spasmolytic agents
ATE15796T1 (de) Benzhydrylsulfinylethylamine, verfahren zu deren herstellung und verwendung in der therapeutik.
ES8606404A1 (es) Amidas dipeptidas analgesicas o antihipertensivas
FR2218107A1 (en) Amino alkyl 2,6-dialkyl-4-aryl-1,4 dihydropyridine-3, carboxylates - useful as cerebral vasodilators and musculotropic spasmolytic agents
ES406637A1 (es) Un procedimiento para la obtencion de derivados de las 1,4 - benzodiazepin-2-onas.
GB1496709A (en) Furotriazines
GB1095783A (en) Process for preparing troponeimines
FR2059944A1 (en) Reductive coupling of halo-organic cpds
DE3866729D1 (de) 4-chloroxazol-derivate, verfahren zu ihrer herstellung und ihre verwendung.
JPS51143650A (en) A process for preparing cyclohexanol derivatives
SE7513795L (sv) Forfarande for framstellning av nya cyklopropylmetylamin-dervat
GB1064176A (en) A method for producing guanylhydrazones
GB1066919A (en) Novel benzyl amine derivatives

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse